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O B J E C T I V E S Our goal was to assess the prevalence of complicated American Heart Association
(AHA) lesion type VI plaques in the carotid arteries of patients with cryptogenic stroke.
B A C KG ROUND In up to 40% of ischemic stroke patients, no deﬁnite cause can be established
despite extensive workup (i.e., cryptogenic stroke). To test the hypothesis if nonstenosing complicated
carotid plaques may be the underlying etiology in some of these patients, we used high-resolution
black-blood carotid magnetic resonance imaging (MRI), which can quantitatively assess plaque
composition and morphology with good correlation to histopathology. Speciﬁcally, we focused on AHA
type VI plaques, which are characterized by hemorrhage, thrombus, or ﬁbrous cap rupture.
METHOD S Thirty-two consecutive patients (22 male; mean age 71.7  11.9 years) with cryptogenic
stroke and nonstenosing (50%) eccentric carotid plaques were recruited from a single stroke unit. All
patients underwent extensive clinical workup (brain MRI, duplex sonography, electrocardiography and
Holter monitoring, transthoracic and transesophageal echocardiography, and laboratory investigations)
to exclude other causes of stroke. All patients received a black-blood carotid MRI at 3-T with
fat-saturated pre- and post-contrast T-1–, proton density–, and T-2–weighted and time-of-ﬂight images
using surface coils and parallel imaging techniques. Prevalence of AHA type VI plaque was determined
in both carotid arteries on the basis of previously published MRI criteria.
R E S U L T S AHA type VI plaques were found in 12 of 32 arteries (37.5%) ipsilateral to the stroke,
whereas there were no AHA type VI plaques contralateral to the stroke (p  0.001). The most common
diagnostic feature of AHA type VI plaques was intraplaque hemorrhage (75%), followed by ﬁbrous
plaque rupture (50%) and luminal thrombus (33%).
CONC L U S I O N S This pilot study suggests that arterio-arterial embolism from complicated, nonste-
nosing carotid atherosclerotic plaques may play a role in a subgroup of patients previously diagnosed with
cryptogenic stroke. To further evaluate the signiﬁcance of AHA type VI plaques in cryptogenic stroke, future
studies will have to analyze both clinical and imaging follow-up data, including event rates for secondary
strokes. (J Am Coll Cardiol Img 2012;5:397–405) © 2012 by the American College of Cardiology Foundation
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398schemic stroke is one of the leading causes of
morbidity and mortality in the western world. Its
etiology is highly heterogeneous: Although large
vessel disease, cardiac embolism, and small vessel
disease account for the majority of cases, most
registries failed to establish a definite cause in up to
40% of patients (i.e., cryptogenic stroke) (1). Im-
portantly, currently used stroke classification schemes
such as TOAST (Trial of Org 10172 in Acute
Stroke Treatment) (2) or A-S-C-O (3) consider
atherosclerotic lesions of the carotid bifurcation
only as causative, if they are associated with sub-
stantial luminal narrowing. However, it has been
See page 406
shown that the degree of luminal stenosis alone is
insufficient to determine a plaque’s vulner-
ability (4,5). More specifically, it has been
demonstrated that roughly 60% of myo-
cardial infarcts occur in coronary arteries
with a stenosis grade of 50% (6,7).
Similarly, several case reports have sug-
gested an association between ischemic
stroke and nonobstructive atherosclerotic
carotid artery plaques (8,9). Thus, arterio-
arterial embolism from nonstenotic ca-
rotid artery lesions may be an attractive
pathophysiological explanation in a sub-
stantial number of patients with crypto-
genic stroke.
Despite these pathophysiological in-
sights, current guidelines for carotid inter-
ventions (10), which are based on data
from large multicenter trials in the 1990s
(11,12), still focus on the degree of lumi-
nal stenosis as the only imaging marker. One
possible explanation for this paradox is that the
ECST (European Carotid Surgery Trial) and the
NASCET (North American Symptomatic Carotid
Endarterectomy Trial) used conventional angiography
as the sole imaging tool; thus, the arterial wall was not
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modalities, such as contrast-enhanced ultrasound,
positron emission tomography/computed tomography
(CT), CT, and high-resolution black-blood carotid
magnetic resonance imaging (MRI), noninvasive
plaque characterization is no longer an elusive goal.
In this study, we applied black-blood carotid
MRI, which has been shown to be a valuable tool to
accurately characterize and quantify the composi-
tion and morphology of human carotid atheroscle-
rotic plaques in vivo with good correlation to
histopathology (13–16). Furthermore, black-blood
carotid MRI allows classification of plaques according to
the criteria of the American Heart Association (AHA)
(17). In particular, complicated AHA lesion type VI,
which is characterized by intraplaque hemorrhage,
thrombus, or rupture of the fibrous cap, can be detected
with a sensitivity of 82% and a specificity of 91%
compared with histopathology (18).
In a study of patients with symptomatic (i.e.,
50%) carotid stenosis, AHA type VI plaques were
shown to be significantly more prevalent on the
symptomatic side than on the asymptomatic side
(19). Furthermore, AHA type VI plaques have been
shown to be associated with a particularly high risk
for causing stroke by arterio-arterial embolization in
patients with 50% carotid stenosis (20,21). Based
on these data, we decided to focus on AHA type VI
plaques in patients without significant luminal narrowing
of the internal carotid artery. Specifically, our goal was to
test the hypothesis that AHA type VI plaques are more
prevalent in nonstenosing arteries ipsilateral than con-
tralateral to a cryptogenic stroke.
M E T H O D S
Setting and diagnostic workup. This pilot study was
onducted at the stroke unit of the Department of
eurology of the Ludwig-Maximilians-University
unich in 2009/2010. All patients were subjected
o the following investigations: laboratory analysis
including electrolytes, differential blood count, co-
gulation studies, and C-reactive protein), 12-lead
lectrocardiography, Holter monitoring, transtho-
acic echocardiography and transesophageal echo-
ardiography (TEE), duplex sonography of the
xtracranial vessels, transcranial Doppler sonogra-
hy and carotid MRI (including T-1–weighted
T-1W], T-2–weighted [T-2W], and diffusion-
eighted imaging [DWI] sequences as well as
ime-of-flight [TOF] magnetic resonance [MR]
ngiography). The aortic arch was evaluated for theB B R E V I A T I O N S
N D A C R O N YM S
AHA American Heart
Association
CT computed tomograph
DWI diffusion-weighted
imaging
MRmagnetic resonance
MRImagnetic resonance
imaging
NWI normalized wall inde
PDW proton
density–weighted
TEE transesophageal
echocardiography
TIA transient ischemic attresence of atherosclerotic plaques by using TEE;
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399in addition, CT angiography (including the aortic
arch) was available in the majority of patients.
Additional tests (e.g., cerebrospinal fluid analysis,
conventional angiography, screening for prothrom-
botic conditions) were performed, where clinically
indicated. Based on the results, patients were grouped
according to the TOAST (Trial of Org 10172 in
Acute Stroke Treatment) classification (2).
Patient selection. Consecutive patients with an isch-
emic stroke in the anterior circulation were screened
for eligibility on the basis of inclusion/exclusion
criteria (Table 1). The study was approved by the
local ethics committee, and all participants provided
written informed consent.
MRI protocol. Participants were subjected to black-
blood carotid MRI within a mean of 5.8 days (4.1
days) after the qualifying stroke. All subjects were
imaged using a previously published multisequence
protocol (22) (TOF MR angiography, axial pre-
and post-contrast black-blood T-1W, proton den-
sity–weighted (PDW), and T-2W sequences; best
in-plane resolution 0.5  0.5 mm2) at 3-T (Mag-
etom Verio, Siemens Healthcare, Erlangen, Ger-
any). To improve signal-to-noise performance
nd optimize spatial resolution, a dedicated
-channel surface coil (Machnet B.V., Eelde, the
etherlands) for bilateral carotid scans was used.
arallel imaging was used for all sequences with a
arallel acquisition technique acceleration factor of
. Imaging time for TOF, T-1W, PDW, and
Table 1. Inclusion/Exclusion Criteria
Inclusion criteria
Ischemic stroke in the territory of the anterior or middle
cerebral artery 14 days before black-blood carotid MRI
(acute DWI lesion and corresponding acute neurological
deﬁcit of 24 h duration)
Nonstenosing (i.e., luminal obstruction 50% according to
NASCET criteria), eccentric (2.0 mm*) atherosclerotic
plaques in the carotid bifurcation as determined by using
duplex sonography
Exclusion criteria
Deﬁnite stroke etiology (TOAST 1–5)†
1 stroke etiology
Bilateral infarcts on carotid MRI
Known contraindications against MRI
Allergy to contrast material
Impaired renal function (glomerular ﬁltration rate 30 ml/min)
Previous radiation therapy to head or neck
Surgical procedure within 24 h before black-blood carotid MRI
*Plaque diameter was determined using duplex sonography in the horizontal
plane. †PFO plus ASA was not regarded as a deﬁnite stroke etiology;
therefore, patients with PFO plus ASA were not excluded from the study.
ASA  atrial septal aneurysm; DWI  diffusion-weighted imaging; MRI 
magnetic resonance imaging; NASCET  North American Symptomatic
Carotid Endarterectomy Trial; PFO  patent foramen ovale; TOAST  Trial ofvOrg 10172 in Acute Stroke Treatment.-2W images were 4:11, 4:38, 2:08, and 2:08 min,
espectively, resulting in a total scan time of 17:43
in. Gadolinium-DTPA-BMA (Gadobutrol,
ayer Schering, Leverkusen, Germany) of 0.1
mol/kg (0.1 ml/kg) was given at a rate of 3 ml/s.
ost-contrast T-1W imaging was performed ap-
roximately 5 min after intravenous injection of the
ontrast agent. Fat suppression was used for pre-
nd post-contrast T-1W, PDW, and T-2W images
o reduce signals from subcutaneous and perivascu-
ar fat. Scan coverage was 3.0 cm, 4.2 cm, 4.2 cm,
nd 5.2 cm for T-1W, PDW, T-2W, and TOF
mages, respectively, resulting in a matched cover-
ge of 30 mm (2-mm slice thickness  15 matched
mages across the 5 sequences). This coverage is
sually sufficient to image the complete carotid
therosclerotic plaque (23). Images were centered
n the carotid bifurcation.
MR imaging review. An image-quality rating (4-
point scale [1  nondiagnostic, 2  poor, 3 
ood, 4  excellent]) was assigned to all MR
mages (22). MR data were independently reviewed
y 2 experienced radiologists (T.S. and J.G.) who
ere blinded regarding the clinical status. In case of
iscrepancy, a consensus decision was made. To
ssess inter-reader reproducibility of AHA type VI
laque, the initial independent investigation of the
reviewers was used for analysis, and one of the
eviewers re-reviewed the images 3 months after
he initial assessment. Atherosclerotic plaques in
he carotid arteries (on both the ipsilateral and the
ontralateral side) were recorded and classified ac-
ording to the modified criteria of the AHA (18).
or definition of a complicated AHA type VI plaque, at
east 1 of the following 3 criteria was required: fibrous cap
upture, intraplaque hemorrhage, or juxtaluminal hem-
rrhage/mural thrombus.
Area measurements of the lumen, wall, outer
all, and tissue components were obtained using a
ustom-designed semiautomatic image analysis tool
ASCADE (University of Washington, Seattle,
ashington) (24). The normalized wall index
NWI) was calculated by dividing the wall area by
he total vessel area. Tissue components (lipid-rich
ecrotic core, calcification, and hemorrhage), the
tatus of the fibrous cap (thick vs. thin vs. ruptured),
emorrhage type (type I [early subacute] versus type
I [late subacute]), and presence/absence of hemor-
hage/thrombus were identified on the basis of
reviously published criteria (14–16).
Statistical analysis. Categorical variables are pre-
ented as absolute and relative frequencies; continuous
ariables are presented as mean SD. Intrareader and
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400inter-reader reproducibility for identification of AHA
type VI plaque were calculated using the Cohen kappa
value. Wilcoxon signed rank test was used to test
differences for continuous variables, and the McNemar
test was used to determine differences between
categorical variables.
All analysis was performed using SAS version 9.2
(SAS Institute, Inc., Cary, North Carolina). A p
value of 0.05 was considered statistically signifi-
ant.
R E S U L T S
Baseline characteristics and diagnostic workup. Dur-
ng the recruitment phase, 33 patients were in-
luded in the study. Thirty-two of 33 MRI scans
97.0%) had an image quality rating of 2 (mean
mage quality: 3.4). All data presented refer to the
2 remaining patients (22 males [68.8%]; mean age
1.7  11.9 years). One asymptomatic artery with
carotid artery stent was excluded from further
nalyses, resulting in 32 symptomatic and 31
symptomatic arteries, which were reviewed.
Most patients had at least 1 of the classical
ascular risk factors or comorbidities. In the major-
ty of patients (n  23 [71.9%]; group A), all
iagnostic tests showed completely normal results.
n 4 patients (12.5%; group B), diagnostic workup
evealed patent foramen ovale plus atrial septal
neurysm but was otherwise not conclusive. Finally,
patients (15.6%; group C) had refused to undergo
EE (or were unable to tolerate the procedure), and
he diagnostic workup was therefore incomplete;
owever, in all of them, transthoracic echocardiog-
aphy was within normal limits. For detailed base-
ine characteristics of included patients, see Table 2.
Prevalence of AHA type VI plaques ipsilateral and
contralateral to cryptogenic ischemic stroke. AHA
type VI plaques were detected in 37.5% (n  12) of
the carotid arteries ipsilateral to the ischemic stroke;
by contrast, no AHA type VI plaques were found
on the contralateral side (p  0.001) (Fig. 1, Table 3).
epresentative examples of an AHA type VI
laque from patients in our series are illustrated in
igures 2 and 3.
For all other AHA lesion types, no significant
ifferences were found between the symptomatic
nd asymptomatic side, although there was a trend
or AHA type III as well as AHA type IV/V being
lightly more prevalent on the asymptomatic side
Fig. 1, Table 3).
The most common diagnostic feature of AHA
T6 plaques was intraplaque hemorrhage (75%),ollowed by fibrous plaque rupture (50%) and lumi-
al thrombus (33%) (Table 3). Of the 9 arteries
ith intraplaque hemorrhage, 5 hemorrhages were
lassified as type I and 4 hemorrhages as type II.
hen we focused only on the subgroup of cryptogenic
troke patients with a completely negative workup
group A), the prevalence of AHA type VI plaques on
he ipsilateral side increased to 39.1% (9 of 23) (as
pposed to 33.3% [3 of 9] in groups B and C
ogether).
Quantitative plaque characteristics ipsilateral and con-
tralateral to cryptogenic ischemic stroke. Quantita-
tive data on plaque burden and composition are
presented in Table 3. No significant differences
were found for minimum and mean lumen areas,
maximum and mean total vessel area, maximum
Table 2. Baseline Characteristics, Diagnostic Workup, and
Patient Subgroups
n %
Male 22 68.8
Vascular risk factors/comorbidities
Nicotine abuse 20 62.5
Arterial hypertension 19 59.4
Hypercholesterolemia 15 46.9
Diabetes mellitus 7 21.9
Positive family history for vascular events 12 37.5
Coronary heart disease 7 21.9
Body mass index 25 kg/m2 18 56.3
Clinical data
NIHSS score at admission
5 29 90.6
5–10 3 9.4
10 0 0
Duration of hospital stay, days
5 8 25
5–10 17 53.1
10 7 21.9
Discharge home 22 68.8
Discharge to rehabilitation facility 10 31.2
Baseline medication
Neither antiplatelet agent nor statin 18 56.2
Antiplatelet agent plus statin 7 21.9
Only antiplatelet agent without statin 5 15.6
Statin only 2 6.3
Diagnostic workup*
All test results WNL (group A) 23 71.9
PFO plus ASA on TEE (group B) 4 12.5
Diagnostic evaluation incomplete
(TEE missing) (group C)
5 15.6
*Numbers refer to patient subgroups A, B, and C.
NIHSS  National Institutes of Health Stroke Scale; TEE  transesophageal
echocardiography; WNL  within normal limits; other abbreviations as in
Table 1.wall area, and mean NWI. Mean wall area and
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401maximum NWI was significantly larger in symp-
tomatic arteries (p  0.03). Furthermore, symp-
omatic arteries had a significantly larger maximum
ecrotic core (p  0.004) and maximum hemor-
hage areas (p  0.02) than asymptomatic arteries.
aximum calcification areas did not differ between
ymptomatic and asymptomatic arteries.
Reproducibility. Intrareader and inter-reader repro-
ducibility for identification of AHA type VI plaque
was excellent, with a Cohen kappa value of 0.90
(p  0.001) and 0.85 (p  0.001), respectively.
D I S C U S S I O N
In line with our hypothesis of an important contri-
bution of atherothrombotic mechanisms, AHA
type VI plaques were found significantly more often
on the ipsilateral side than on the contralateral side
in the overall group (37.5% vs. 0.0%; p  0.001).
These data suggest that in a subgroup of our
patients previously classified as cryptogenic, the
stroke was caused by arterio-arterial embolization
from these nonobstructive but complicated athero-
sclerotic lesions.
In addition to the AHA classification, plaques were
also analyzed with respect to several quantitative
parameters. Although parameters indicating plaque
composition were significantly different between
symptomatic and asymptomatic arteries, no significant
differences were noted for measurements reflecting the
degree of luminal stenosis as well as for the majority of
AHA Lesion Type Distribution 
in Symptomatic Arteries
(n=32)
38%
28%
12%
0%
9%13%
Figure 1. AHA Lesion Type Distribution
The relative frequency of the different American Heart Association
arteries; 1 asymptomatic artery with a carotid artery stent was excluparameters reflecting pure plaque burden; thus, thisobservation adds further evidence to the concept of
plaque composition being a major determinant of
plaque vulnerability of atherosclerotic lesions.
From an overall perspective, our data confirm the
recent findings of Parmar et al. (25), who, in a large
sample of patients referred with clinically suspected
acute transient ischemic attack (TIA) or stroke
found type VI lesions to be significantly associated
with ipsilateral acute TIA or stroke. Their study
highlights the general pathophysiological relevance
of type VI plaques but did not directly address their
role specifically for cryptogenic stroke. In detail,
there are a number of differences between both
studies. First, the patient selection criteria used by
Parmar et al. (25) were substantially different: the
authors focused not only on manifest strokes but
also included cases with TIA or transient monocu-
lar blindness. Beyond this, Parmar et al. (25)
included patients irrespective of the degree of ca-
rotid stenosis. In addition, their study was not
performed in the standardized setting of a stroke
unit (i.e., without neurologists as an integral part of
the study team). As a consequence of this overall
setting and due to the specific recruitment strategy
from both inpatients and the emergency department,
their study cohort is more heterogeneous than our
sample. Moreover, phenotypes of patients were deter-
mined only retrospectively on the basis of chart review.
Strengths of our study include: 1) an interdisci-
plinary study team comprising both vascular neu-
AHA Lesion Type Distribution
in Asymptomatic Arteries
(n=31)
0%
0%
13%
29%48%
10%
e I
e III
e IV/V
e VI
e VII
e VIII
) lesion types is presented for symptomatic and asymptomatic
.Typ
Typ
Typ
Typ
Typ
Typ
(AHArologists and (neuro)radiologists; 2) prospective pa-
e
fi
AHA  American Heart A
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402tient recruitment, using a pre-defined set of
inclusion/exclusion criteria in the setting of a single
large stroke unit in a tertiary referral center; and
3) reliable phenotyping of all patients based on
comprehensive and standardized neurological and
etiological workup. The criteria we used for the
definition of cryptogenic stroke were rather strict;
for example, patients with 2 potential stroke
tiologies (which according to the TOAST classi-
cation qualify as cryptogenic) as well as patients
without evidence of an obvious source of cardiac
embolism but with bilateral infarcts (i.e., with a
high degree of suspicion of cardioembolic stroke)
were not included in our study. Furthermore, as
part of the routine workup, in most patients we
also performed an evaluation of the aortic arch
(using TEE or CT angiography) to exclude more
proximal potential sources of arterio-arterial em-
bolism.
In our trial, plaque imaging data were obtained
acteristics Ipsilateral and Contralateral to Cryptogenic
Symptomatic
Side
(n  32)
Asymptomatic
Side
(n  31)* p Value†
ution
37.5 (12) 0.0 (0) 0.001
rrhage 9/12 (75%) 0.0 (0)
re 6/12 (50%) 0.0 (0)
4/12 (33%) 0.0 (0)
9.4 (3) 12.9 (4) 0.66
12.5 (4) 29.0 (9) 0.13
28.2 (9) 48.4 (15) 0.13
4/9 (44%) 2/13 (15%)
5/9 (56%) 11/15 (73%)
12.5 (4) 9.7 (3) 0.71
0.0 (0) 0.0 (0)
a (mm2) 12.9 5.8 13.9 5.9 0.45
m2) 28.9 10.4 28.8 9.6 0.93
(mm2) 60.0 22.7 55.0 18.0 0.10
2) 36.8 12.0 32.3 9.2 0.01
el area (mm2) 107.9 37.4 107.6 34.0 0.95
ea (mm2) 65.7 19.7 61.1 16.3 0.08
0.71 0.11 0.66 0.10 0.03
0.57 0.07 0.54 0.08 0.09
m2)
ore area 9.1 9.1 3.8 4.7 0.004
n area 1.3 1.9 1.8 2.9 0.31
ge area 3.7 8.2 0.0 0.0 0.02
or mean  SD unless otherwise indicated. *One asymptomatic artery with a
cluded. †Wilcoxon signed rank test or paired t test.
ssociation; N/A  not applicable; NWI  normalized wall index.not as part of the acute stroke imaging MR protocolbut in a separate dedicated imaging session. There-
fore, the latency between the qualifying stroke and
black-blood carotid MRI was roughly 1 week in the
majority of patients, which is obviously longer than
in the study by Parmar et al. (25). However, because
plaque morphology has been shown to be relatively
stable over a long period of time (26), our findings
at the time of data acquisition most likely ade-
quately reflect the status of the atherosclerotic
plaques at the time of the qualifying stroke. Fur-
thermore, because black-blood carotid MRI was
not performed in the peracute setting, patients were
more likely to be in a clinically stable condition,
allowing adequate compliance with the study pro-
tocol; accordingly, image quality was consistently
high in 32 of our 33 patients (97.0%), as opposed to
the recent 1.5-T study of Parmar et al. (25), who
had to exclude 20% of studies because of poor image
quality (e.g., due to motion artifacts). The number
of subjects excluded in our study due to insufficient
image quality is also substantially lower than in a
recent 1.5-T multicenter trial by Boussel et al.
(27), in which 32.5% of all subjects had to be
excluded. A further reason for the lower number
of excluded examinations in our study compared
with previous 1.5-T MR studies might be the
signal gains associated with the higher field
strength at 3-T in combination with the shorter
scan time due to the parallel imaging techniques
used in our study (22). This short scan time is
easier to tolerate for the patients and might
therefore result in less motion artifacts as well as
artifacts due to patient swallowing.
To further expand on the findings presented
here, future trials (including control patients with
other defined stroke etiologies) will have to deter-
mine the therapeutic implication the finding of a
complicated AHA type VI plaque ipsilateral to a
cryptogenic stroke has (i.e., whether these patients
may benefit from an escalated medical [dual platelet
inhibition] or interventional/surgical treatment ap-
proach). To this purpose, it will be essential to
generate both clinical and imaging follow-up data,
including event rates for secondary strokes; these
and other aspects will be addressed in a recently
initiated prospective study (Carotid Plaque Imaging
in Acute Stroke [NCT01284933]).
Interestingly, results from several studies suggest
that certain plaque characteristics, including in
particular intraplaque hemorrhage, as determined
by black-blood carotid MRI, may indeed predict a
less favorable clinical outcome. A prospective inTable 3. Plaque Char
Ischemic Stroke
AHA lesion type distrib
Type VI
Intraplaque hemo
Fibrous cap ruptu
Thrombus
Type I
Type III
Type IV/V
Thin ﬁbrous cap
Thick ﬁbrous cap
Type VII
Type VIII
Plaque burden
Minimum lumen are
Mean lumen area (m
Maximum wall area
Mean wall area (mm
Maximum total vess
Mean total vessel ar
Maximum NWI
Mean NWI
Plaque composition (m
Maximum necrotic c
Maximum calciﬁcatio
Maximum hemorrha
Values are % (n), n/N (%),
carotid artery stent was exvivo MRI study (20) investigated plaque character-
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403istics in 154 subjects with an initially asymptomatic
50% to 79% carotid stenosis. Plaques with intra-
plaque hemorrhage and larger mean intraplaque hem-
orrhage area were found to be significantly associated
with subsequent cerebrovascular events over a mean
follow-up period of 38.2 months. Similar observations
were made in a study of 66 patients with high-grade
symptomatic stenosis (28), in which intraplaque hem-
orrhage significantly increased the risk of a secondary
stroke. Based on these and other similar data (29,30),
future studies will have to address the predictive value
of plaque characteristics specifically for patients with
cryptogenic stroke.
Study limitations. Scan coverage ranged from 3.0 cm
for T-1W and 5.2 cm for TOF images. Therefore,
carotid lesions further up-stream or down-stream
could have been missed due to insufficient coverage.
However, based on our experience, carotid endar-
terectomy specimens are usually short and rarely
exceed 2 cm in length (14). Thus, we believe that
we have covered the majority of lesions that were
centered around or at the carotid bifurcation.
No histology data were available in our patients,
and our results therefore rely by design on the in
vivo MRI data. However, black-blood MRI has
been extensively validated against histopathology
(14,15,18,31,32); in particular, AHA type VI
plaque can be reliably identified using MRI with
excellent sensitivity and specificity. However, spa-
tial resolution of MRI is limited, and we may
therefore have missed small hemorrhages, thrombi,
Figure 2. Nonobstructive AHA Type VI Plaque
This nonstenosing plaque was detected in a 66-year-old male patie
on the time-of-ﬂight (TOF) and proton density–weighted (PDW) ima
large lipid/necrotic core with type I hemorrhage, which does not ca
Abbreviation as in Figure 1.or fibrous cap ruptures. The true prevalence ofAHA type VI plaque might be higher than reported
in our paper.
The majority of patients included in our study
had one or more of the classical vascular risk factors,
which obviously increased the a priori probability of
finding evidence for atherosclerosis-mediated
stroke mechanisms. Thus, the yield of complicated
plaques might have been substantially lower in a
cohort of cryptogenic stroke patients with a less
pronounced vascular risk factor profile. However,
we feel that this patient selection by no means limits
the impact of our results; given the high prevalence
of patients with multiple risk factors in most stroke
units, we are convinced that our cohort adequately
reflects the phenotype of a “typical” stroke patient.
Similarly, only patients with eccentric plaques at the
carotid bifurcation of 2 mm were included, which
may also have caused some overestimation of the
prevalence of AHA type VI plaque. However, to
avoid unnecessary and expensive carotid MRI ex-
aminations, it is both economically and medically
reasonable to use ultrasound as a screening tool.
One might argue that our overall cryptogenic
group was contaminated by some patients with
incomplete diagnostic workup (group C) or with
findings of unclear causality (group B). However,
we can exclude that these factors substantially
biased our results because the prevalence of AHA
type VI plaques even increased when we focused
exclusively on the group of patients with the strict-
ith a cryptogenic stroke ipsilateral to the lesion. The arrowheads
point to the site of the plaque rupture. The arrows point to a
substantial luminal narrowing (see TOF images on the left).nt w
ges
useest definition of cryptogenic stroke.
mures
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Using black-blood carotid MRI, we provide com-
pelling evidence that a substantial proportion of
strokes previously classified as cryptogenic is related
to nonstenosing, complicated AHA type VI plaques
(i.e., atherothrombotic mechanisms).
Figure 3. Nonobstructive AHA Type VI and Type IV/V Plaques
(A) This nonobstructive AHA type VI plaque was detected in a 7
days before the magnetic resonance imaging scan. The arrow po
images, which is indicative of juxtaluminal hemorrhage/thrombu
to the site of possible plaque rupture. The lesion consists of a la
rowing (see coronal CE–T-1W images on the left). (B) Images of
contralateral to the cryptogenic stroke, causing luminal narrowin
T-1W and TOF images and isointense to hypointense on PDW an
post-contrast T-1W images, consistent with a lipid/necrotic core.
lipid/necrotic core, consistent with a thick ﬁbrous cap. The imag
surrounded by a yellow dotted line; the thick ﬁbrous cap is mar
type IV/V. CE  contrast-enhanced; other abbreviations as in FigReprint requests and correspondence: Dr. Tobias M.
Freilinger, Neurologische Klinik und Poliklinik und
Institut für Schlaganfall- und Demenzforschung,
Klinikum Großhadern der Ludwig-Maximilians-
Universität München, Marchioninistrasse 15, 81377
München, Germany. E-mail: tobias.freilinger@med.uni-
uenchen.de.
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necrotic core, which does not cause substantial luminal nar-
same patient showing an obstructive atherosclerotic lesion
f 60%. The arrow points to a region, which is isointense on
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